Utilidad de la PETFDG en la valoracion de la respuesta del cancer de mama, de esofago y de pulmon: Revision sistematica de los resultados tras la terapia neoadyuvante [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
Rebollo Aguirre AC, Villegas Portero R, Ramos Font C
 
 
Record Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Citation
Rebollo Aguirre AC, Villegas Portero R, Ramos Font C. Utilidad de la PETFDG en la valoracion de la respuesta del cancer de mama, de esofago y de pulmon: Revision sistematica de los resultados tras la terapia neoadyuvante. [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2006/15. 2009
Authors' objectives

The aim of the present report was assessing the performance of positron emission tomography (PET or PET-CT with fluordeoxyglucose -F18, as diagnostic test, in assessing the response to neoadjuvant treatment of patients with oesophagus cancer, breast cancer, non-small cell lungs cancer (NSCLC), in terms of diagnostic validity and clinical utility.

Project page URL
http://www.juntadeandalucia.es/salud/servicios/contenidos/nuevaaetsa/up/AETSA_ 2006-15_ PET_ FDG.pdf
Final publication URL
http://www.juntadeandalucia.es/salud/servicios/contenidos/nuevaaetsa/up/AETSA_ 2006-15_ PET_ FDG_ eng.pdf
Indexing Status
Subject indexing assigned by CRD
MeSH
Breast Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18s; Lung Neoplasms; Lymphoma; Positron-Emission Tomography
Language Published
Spanish
Country of organisation
Spain
English Summary
English summary available
Address for correspondence
Agencia de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. de la Innovacion s/n Edificio Renta Sevilla 2a planta 41020 Sevilla (Espana) Telf. +34 955407234 Fax + 34 955407238 Email: aetsa.csalud@juntadeandalucia.es
AccessionNumber
32008100427
Date abstract record published
02/03/2009
 
Health Technology Assessment (HTA) database
Copyright © 2026 Andalusian Agency for Health Technology Assessment (AETSA)
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for HTA database users